Caisse de depot et placement du Quebec Makes New $150.39 Million Investment in Nutrien Ltd. $NTR

Caisse de depot et placement du Quebec purchased a new position in shares of Nutrien Ltd. (NYSE:NTRFree Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 2,387,942 shares of the company’s stock, valued at approximately $150,388,000.

Several other institutional investors and hedge funds have also modified their holdings of NTR. Guggenheim Capital LLC increased its stake in shares of Nutrien by 2.2% in the 4th quarter. Guggenheim Capital LLC now owns 6,628 shares of the company’s stock worth $409,000 after purchasing an additional 145 shares in the last quarter. Minot DeBlois Advisors LLC raised its holdings in Nutrien by 1.8% in the 4th quarter. Minot DeBlois Advisors LLC now owns 9,032 shares of the company’s stock worth $557,000 after purchasing an additional 164 shares during the period. Banque Cantonale Vaudoise lifted its position in Nutrien by 15.9% during the first quarter. Banque Cantonale Vaudoise now owns 1,198 shares of the company’s stock valued at $90,000 after purchasing an additional 164 shares in the last quarter. Gould Asset Management LLC CA lifted its position in Nutrien by 4.4% during the first quarter. Gould Asset Management LLC CA now owns 3,933 shares of the company’s stock valued at $297,000 after purchasing an additional 165 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its position in Nutrien by 21.8% during the fourth quarter. EverSource Wealth Advisors LLC now owns 983 shares of the company’s stock valued at $61,000 after purchasing an additional 176 shares in the last quarter. Hedge funds and other institutional investors own 63.10% of the company’s stock.

Nutrien Trading Up 1.2%

Shares of Nutrien stock opened at $73.72 on Thursday. The company has a market capitalization of $35.26 billion, a P/E ratio of 14.92, a P/E/G ratio of 0.74 and a beta of 0.61. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.86 and a current ratio of 1.39. The company has a fifty day moving average of $66.91 and a 200 day moving average of $70.51. Nutrien Ltd. has a fifty-two week low of $53.03 and a fifty-two week high of $85.36.

Nutrien (NYSE:NTRGet Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $2.61 EPS for the quarter, missing analysts’ consensus estimates of $2.70 by ($0.09). Nutrien had a net margin of 8.44% and a return on equity of 8.88%. The business had revenue of $10.81 billion for the quarter, compared to the consensus estimate of $10.44 billion. During the same period in the prior year, the business earned $2.65 earnings per share. Nutrien’s revenue was up 3.6% compared to the same quarter last year. On average, sell-side analysts anticipate that Nutrien Ltd. will post 4.95 earnings per share for the current fiscal year.

Nutrien Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 16th. Investors of record on Tuesday, September 29th will be given a dividend of $0.55 per share. The ex-dividend date is Tuesday, September 29th. This represents a $2.20 annualized dividend and a dividend yield of 3.0%. Nutrien’s dividend payout ratio (DPR) is currently 44.53%.

Analyst Upgrades and Downgrades

NTR has been the subject of a number of analyst reports. TD Securities restated a “buy” rating on shares of Nutrien in a research report on Wednesday, May 6th. Barclays lowered their price objective on Nutrien from $81.00 to $78.00 and set an “overweight” rating on the stock in a research report on Monday, August 10th. Morgan Stanley cut their price objective on Nutrien from $93.00 to $81.00 and set an “overweight” rating for the company in a research note on Tuesday, July 7th. Oppenheimer reduced their target price on shares of Nutrien from $82.00 to $80.00 and set an “outperform” rating for the company in a report on Thursday, July 23rd. Finally, UBS Group decreased their target price on shares of Nutrien from $67.00 to $65.00 and set a “sell” rating on the stock in a research note on Monday, May 11th. Seventeen research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $81.58.

Get Our Latest Stock Analysis on Nutrien

About Nutrien

(Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Featured Stories

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.